Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.7500
-0.0400 (-5.06%)
Mar 13, 2026, 4:20 PM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 90.6 million as of March 13, 2026. Its market cap has decreased by -46.37% in one year.
Market Cap
90.60M
Enterprise Value
91.72M
Revenue
32.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
Market Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 90.60M, an increase of 78.03%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 90.60M | -16.81% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 68.58B |
| Sigma Healthcare | 31.29B |
| Pro Medicus | 14.29B |
| Cochlear | 11.99B |
| Paradigm Biopharmaceuticals | 114.21M |
| BlinkLab | 103.87M |
| Arovella Therapeutics | 91.14M |
| Alterity Therapeutics | 87.00M |